Titre:
  • Multifactorial approach to predicting resistance to anthracyclines.
Auteur:Desmedt, Christine; Di Leo, Angelo; Azambuja, Evandro; Larsimont, Denis; Haibe-Kains, Benjamin; Selleslags, Jean; Delaloge, Suzette; Duhem, Caroline; Kains, Jean-Pierre; Carly, Birgit; Maerevoet, Marie; Vindevoghel, Anita; Rouas, Ghizlane; Lallemand, Françoise; Durbecq, Virginie; Cardoso, Fatima; Salgado, Roberto; Kraft Rovere, Rodrigo; Bontempi, Gianluca; Michiels, Stefan; Buyse, Marc; Nogaret, Jean-Marie; Qi, Yuan; Symmans, Fraser; Pusztai, Lajos; D'Hondt, Veronique; Piccart-Gebhart, Martine; Sotiriou, Christos
Informations sur la publication:Journal of clinical oncology, 29, 12, page (1578-1586)
Statut de publication:Publié, 2011-04
Sujet CREF:Cancérologie
Sciences biomédicales
MeSH keywords:Antibiotics, Antineoplastic -- adverse effects -- therapeutic use
Antigens, Neoplasm -- analysis -- genetics
Biopsy
Breast Neoplasms -- drug therapy -- enzymology -- genetics -- pathology
Chemotherapy, Adjuvant
DNA Topoisomerases, Type II -- analysis -- genetics
DNA-Binding Proteins -- analysis -- antagonists & inhibitors -- genetics
Drug Resistance, Neoplasm -- genetics
Epirubicin -- adverse effects -- therapeutic use
Europe
Female
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
Middle Aged
Neoadjuvant Therapy
Odds Ratio
Patient Selection
Predictive Value of Tests
Prospective Studies
Receptor, erbB-2 -- analysis
Receptors, Estrogen -- analysis
Reproducibility of Results
Risk Assessment
Risk Factors
Texas
Treatment Failure
Tumor Markers, Biological -- analysis
Note générale:Journal Article
Multicenter Study
Randomized Controlled Trial
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2010.31.2231
info:pii/JCO.2010.31.2231
info:scp/79955008762
info:pmid/21422418